Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. - Wikidata - wikimedia - TriplyDB

Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure.

Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure.

http://www.wikidata.org/entity/Q35501399

about

Light chain (AL) amyloidosis: update on diagnosis and management In vitro inhibition of transthyretin aggregate-induced cytotoxicity by full and peptide derived forms of the soluble receptor for advanced glycation end products (RAGE)Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component Pentraxins: structure, function, and role in inflammation Serum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae.Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue.Examining serum amyloid P component microheterogeneity using capillary isoelectric focusing and MALDI-MS Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical use.Novel approaches to the treatment of primary amyloidosis.The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo.Dynamic PET and SPECT imaging with radioiodinated, amyloid-reactive peptide p5 in mice: a positive role for peptide dehalogenation.Amyloid-like IgM deposition neuropathy: a distinct clinico-pathologic and proteomic profiled disorder Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy DC-SIGN activation mediates the differential effects of SAP and CRP on the innate immune system and inhibits fibrosis in mice Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen Amyloid accomplices and enforcers Pattern recognition by pentraxins The "sweet" side of a long pentraxin: how glycosylation affects PTX3 functions in innate immunity and inflammation.Drug Insight: emerging therapies for amyloidosis.Function and control of human invasive trophoblast subtypes: Intrinsic vs. maternal control.Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity.In situ characterization of protein aggregates in human tissues affected by light chain amyloidosis: a FTIR microspectroscopy study.Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene SAP suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.beta(2)-microglobulin: from physiology to amyloidosis.Proteomic typing of amyloid deposits in systemic amyloidoses.Light-chain amyloidosis: SCT, novel agents and beyond.Clinical proteomics for diagnosis and typing of systemic amyloidoses.The long pentraxin PTX3: a paradigm for humoral pattern recognition molecules.Characterization of heparin binding by a peptide from amyloid P component using capillary electrophoresis, surface plasmon resonance and isothermal titration calorimetry.Advances in proteomic study of cardiac amyloidosis: progress and potential.Loss of prohormone convertase 2 promotes beta cell dysfunction in a rodent transplant model expressing human pro-islet amyloid polypeptide.Amyloid plaques beyond Aβ: a survey of the diverse modulators of amyloid aggregation.Fibrillar amyloid protein present in atheroma activates CD36 signal transduction.A unique biofilm in human deep mycoses: fungal amyloid is bound by host serum amyloid P component.Investigating interactions of the pentraxins serum amyloid P component and C-reactive protein by mass spectrometry.New features of invasive candidiasis in humans: amyloid formation by fungi and deposition of serum amyloid P component by the host.

P2860

Q21198863-A1C6687A-8660-4507-9AAA-7740D945CA9C Q24337632-497854E2-480D-48AD-AF3E-FBE3205645E0 Q24337745-501E26CD-F0FA-4461-8003-F612B41756B5 Q24562844-8A9F7E4A-D78E-4BD2-99AF-9769BC043D5D Q27654862-6CDF6050-9A48-4947-B55C-2401CE050340 Q28676262-862B61A3-DED9-423D-A84D-0E4DFF1A8F77 Q33298405-732F6847-96A3-431D-BB74-56856B0ED925 Q33715284-1AD8802C-DC99-4529-8C3E-D87271608E79 Q33779346-9C482A9F-3779-407D-8490-69B3D63D9072 Q33796862-DD2C8872-B11F-41D0-87DF-51C8BFF0446C Q34075126-DEF069FC-D7EC-4D83-A4D3-1F8332B71D05 Q34188358-F9FF77F4-E692-452A-8C34-E5D31B2229B8 Q34216798-A12529DD-11C0-4F42-A301-F770FD4EA651 Q34317497-FDEF14DD-B834-414A-998F-5FB1A0F13BC5 Q35764345-4CDDE5BF-305A-4643-924A-AD664367C27A Q35845691-4343A6A4-E4B6-4AC8-824B-EF7C92B523C2 Q35850904-2A0A20CB-E777-4134-869A-15E8DBE67301 Q35970547-BA725542-9720-4CFE-892D-8FB6396F0136 Q36008865-F232AC8B-A19E-40DD-BDC6-22DD5B9A14D1 Q36516810-22197136-C9D4-4F2A-BB29-ACBC30F044E8 Q36577160-689ED4DF-9094-4313-93DC-9234AC6AE8D9 Q36857915-0E694FE5-D706-4DA0-BB8E-63EC5A984C3D Q37030603-E115C742-1D7F-4A0C-9FA3-DE70FD54EFF9 Q37061542-D4C149F3-A06A-4462-AC45-55E71646A91C Q37356259-AA22B6A5-2418-493D-A559-90C62B56E8CF Q37433362-54502388-4D67-4693-8957-87D7F957E19C Q37459593-2EF3597A-724B-4584-97CC-7729B8317880 Q37573510-D4BD5CE6-2D5B-47B9-8B03-6B15055F8CD6 Q37955712-A37598B0-F659-472B-9DF7-C271E3E235BE Q38056010-A6B01D5F-330D-4F7D-ACCD-48BAC0009C04 Q38062901-E61124AB-9FE4-41F9-9F7E-3F2E941FF080 Q38092832-D1954B5D-D988-42A7-A0B5-03135191CCD7 Q38288025-7C42E1B1-429C-4606-9AD1-3EB8E98B4752 Q38809423-404704F3-5A66-46BB-BFA5-FD9385F27E31 Q39079601-9458607E-7E86-45C3-8650-1DCF9BADFA84 Q39385143-40733963-0E85-464F-9A61-9B0E4CE924C0 Q40603203-8098D3FD-0333-48BF-8AF6-BBC95EE919EB Q41002244-037F53D6-E46A-4AF3-BE7E-7635B442F256 Q41877441-FBEE5EAA-9986-4D8D-87C4-E6B716EA47EA Q42057069-014B579F-81F3-4AF7-8A14-3664C1BB0220

P2860

Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure.

http://www.wikidata.org/entity/Q35501399

description

1994 nî lūn-bûn

@nan

1994 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Human serum amyloid P componen ...... ly homogeneous glycostructure.

@ast

Human serum amyloid P componen ...... ly homogeneous glycostructure.

@en

type

label

Human serum amyloid P componen ...... ly homogeneous glycostructure.

@ast

Human serum amyloid P componen ...... ly homogeneous glycostructure.

@en

prefLabel

Human serum amyloid P componen ...... ly homogeneous glycostructure.

@ast

Human serum amyloid P componen ...... ly homogeneous glycostructure.

@en

P1433

Q35501399-76C77334-BCF6-46B4-8C69-5F418BE4CD9A

P1476

Q35501399-E1DDA4FE-D6D5-4EAB-AD13-E2F43D60A656

P2093

Q35501399-3B7510FD-0B3E-4C9B-B822-D4AC40054E65

Q35501399-4C360C0F-6CEA-4B2B-BB94-A138C05B4DDF

Q35501399-8569725E-B8C2-4B5B-9F38-B7E64C582B0F

Q35501399-87034A14-A721-4D6F-963B-AEE314DBA667

Q35501399-9FB4EE6E-5C93-49D4-ABBE-E4D503482F6A

Q35501399-C528007A-9146-4CFE-80A3-5DEB636253A3

Q35501399-D502B39B-EBDD-4373-B7E5-6E663A221E4E

Q35501399-E0460557-E224-4F92-AA02-45668D43B604

Q35501399-E86F8AB0-EB7F-45F8-A75F-0C55CF7A93F1

P2860

Q35501399-01A08B7F-442A-4A3B-AE1A-99E3096F47EA

Q35501399-11A1A7C3-BE25-475A-A00B-3459B1887C5F

Q35501399-1D67D42F-0CD6-4DFA-A8B7-612B303E39BA

Q35501399-2A32B37F-E075-4DFA-8D18-DFF6E8E320EB

Q35501399-2FC6E4A3-F72D-4803-B95D-E949D35676B5

Q35501399-3704F5EE-0CB3-4BB0-87EA-73A631C9427C

Q35501399-3D2BEEE5-699B-4067-81B8-0B5BFF8901CC

Q35501399-4C3E3D94-5DCC-4DBF-9220-292150351C6C

Q35501399-5CAA8490-1390-4CAF-85DE-3767C7B774B7

Q35501399-6318279D-F583-45BC-9C4C-82C424E6EDCD

P304

Q35501399-1F84FFE4-0327-4051-B2F8-1026CDD1C120

P31

Q35501399-0EF846DD-F1F1-4240-AEDA-CCA9D596C409

P356

Q35501399-A1083C53-5BA7-4CCE-BA1F-2EAF4A7DEAA7

P407

Q35501399-1C5DFB6C-0AE0-42D7-A45D-FF3E1DDEB6D2

P433

Q35501399-1BD4222A-F26B-4CFA-A3A1-A93F41114086

P478

Q35501399-2C01AE8C-53BC-460C-B6B8-D6560883ACE1

P50

Q35501399-729EE2D6-7733-4300-BBF2-A4BB19C0F604

P577

Q35501399-A64564C1-265E-48D6-8680-B1AA1132697D

P5875

Q35501399-6F83FFCB-D8E3-4597-8566-0DEA01554FFB

P698

Q35501399-0F96A36F-C64F-4887-841D-20299B0761DA

P932

Q35501399-5362472B-8E32-475A-98E8-64F525F28888

P356

PNAS.91.12.5602

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Human serum amyloid P componen ...... ly homogeneous glycostructure.

@en

P2093

G E Noble

http://www.w3.org/2001/XMLSchema#string

J Herbert

http://www.w3.org/2001/XMLSchema#string

J R Gallimore

http://www.w3.org/2001/XMLSchema#string

P N Hawkins

http://www.w3.org/2001/XMLSchema#string

P Williams

http://www.w3.org/2001/XMLSchema#string

S Amatayakul-Chantler

http://www.w3.org/2001/XMLSchema#string

S R Nelson

http://www.w3.org/2001/XMLSchema#string

T W Rademacher

http://www.w3.org/2001/XMLSchema#string

W L Hutchinson

http://www.w3.org/2001/XMLSchema#string

P2860

Human serum amyloid P component. cDNA isolation, complete sequence of pre-serum amyloid P component, and localization of the gene to chromosome 1

Structure of pentameric human serum amyloid P component

The asialoglycoprotein receptor: properties and modulation by ligand

Isolation and characterization of C-reactive protein and serum amyloid P component in the rat

Serum amyloid P component is the major calcium-dependent specific DNA binding protein of the serum

Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease.

Specific chemical dissociation of fibrillar and non-fibrillar components of amyloid deposits.

Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component.

Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis.

A protease-sensitive site in the proposed Ca(2+)-binding region of human serum amyloid P component and other pentraxins

P304

5602-5606

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.91.12.5602

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P50

P577

1994-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14995801

http://www.w3.org/2001/XMLSchema#string

P698

8202534

http://www.w3.org/2001/XMLSchema#string

P932

44044

http://www.w3.org/2001/XMLSchema#string